Additionally, genetic studies have demonstrated that functional polymorphisms in two genes involved in carcinogen metabolism (N-acetyltransferase 2 [NAT2] and glutathione S-transferase M1 [GSTM1]) are associated with bladder cancer risk [20], [21]. This evidence concerns the gene GSTM1 and urinary bladder carcinoma.